Zydus Healthcare gets Rs 284.58 crore income tax demand notice Roshni Dhar28 Dec 2023 5:51 PM ISTZydus Lifesciences on Tuesday said its arm Zydus Healthcare Ltd has been served an income tax notice demand of Rs 284.58 crore for the assessment year...
Health Bulletin 28/December/2023 Roshni Dhar28 Dec 2023 4:16 PM ISTHere are the top health stories for the day:Delhi: CISF seizes medicines worth Rs 80 lakh at IGI airport, two heldTwo international passengers were...
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Ruchika Sharma27 Dec 2023 3:29 PM ISTThe demand is determined due to "apparent mistakes while processing its return of income', it said.
USFDA issues 6 observations for Zydus Lifesciences Ahmedabad facility Ruchika Sharma23 Dec 2023 11:30 AM ISTAhmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has closed the inspection with 6...
Zydus Lifesciences arm Zydus Noveltech dissolves Ruchika Sharma19 Dec 2023 3:33 PM ISTAhmedabad: Zydus Lifesciences has announced that Zydus Noveltech Inc., USA, (ZNI) a wholly owned subsidiary of the Company, incorporated in New...
Zydus Lifesciences gets USFDA nod to begin Phase II clinical trial of ZYIL1 in Parkinson's disease patients Ruchika Sharma18 Dec 2023 12:30 PM ISTZydus has been granted an 'Orphan Drug Designation' by the US FDA for ZYIL1 in treatment of patients with CAPS, a rare auto-inflammatory disease.
Seizure drug: Zydus Lifesciences gets USFDA approval for Lacosamide tablets Ruchika Sharma16 Dec 2023 12:45 PM ISTThe product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad.
Zydus Lifesciences bags USFDA nod for HIV-1 drug Darunavir Ruchika Sharma15 Dec 2023 3:00 PM ISTDarunavir must be -co-administered with Ritonavir and with other antiretroviral agents.
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
Zydus Lifesciences gets USFDA okay for acquired methemoglobinemia injection Methylene Blue Ruchika Sharma6 Dec 2023 3:30 PM ISTMethylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Zydus Lifesciences US arm concludes asset transfer of CUTX-101 for Menkes disease from Cyprium Therapeutics Ruchika Sharma6 Dec 2023 1:30 PM ISTSentynl now assumes full responsibility for the development and commercialization of CUTX-101.
Zydus Lifesciences gets USFDA nod for heart failure drug Ivabradine Ruchika Sharma1 Dec 2023 2:36 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
